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Clinics and pathology 
Disease 
Giant cell tumour of bone is a locally destructive 
tumor, usually seen in patients over 20 years of age,  
borderline lesion between benign and malignant 
tumours, with a good prognosis, despite of recurrences 
and, more rarely, pulmonary metastases. The most 
frequent genetic finding is telomeric associations. 
Genetics 
Note 
In a study by Scotlandi et al., 2000, was found that a 
minor population of cells from giant cell tumour of
bone samples had an EWSR1/FLI1 transcript, but this 
was found in a high percentage of samples (13/15). 





From N-term to C-term: a 5' ETS domain, a Fli-1-
specific transcriptional activation domain, and a 3' ETS 
transcriptional activation domain. Member of ETS 
transcription factor gene family. FLI1 binds to DNA in 








From N-term to C-term: a transactivation domain 
(TAD) containing multiple degenerate hexapeptide 
repeats, 3 arginine/glycine rich domains (RGG 
regions), a RNA recognition motif, and a RanBP2 type 
Zinc finger. Role in transcriptional regulation for 
specific genes and in mRNA splicing. 




5' EWSR1 - 3' FLI1. EWSR1 exon 7 is fused in frame 
to FLI1 exon 6 and/or 5 (type 1 and type 2 fusions 
respectively), indicating, when both transcripts were 
produced in a given sample, genetic heterogeneity 
within the tumour. 
Fusion Protein 
Description 
Fusion of the N terminal transactivation domain of 
EWSR1 to the ETS type DNA binding domain of FLI1. 
References 
Scotlandi K, Chano T, Benini S, Serra M, Manara MC, 
Cerisano V, Picci P, Baldini N. Identification of EWS/FLI-1 
transcripts in giant-cell tumor of bone. Int J Cancer. 2000 Aug 
1;87(3):328-35 
This article should be referenced as such: 
Huret JL. t(11;22)(q24;q12) in giant cell tumour of bone. Atlas 
Genet Cytogenet Oncol Haematol. 2011; 15(3):299. 
 
 
